Axtria Launches LUCCID to Transform Clinical Data Management with GenAI
Delivers Technology for Automating Unstructured Clinical Data Extraction with Over 90% Accuracy BERKELEY HEIGHTS, N.J., April 29, 2025 /PRNewswire/ --...
Pharmaceutical
Axtria Launches LUCCID to Transform Clinical Data Management with GenAI
Delivers Technology for Automating Unstructured Clinical Data Extraction with Over 90% Accuracy BERKELEY HEIGHTS, N.J., April 29, 2025 /PRNewswire/ --...
Axtria Launches LUCCID to Transform Clinical Data Management with GenAI
Delivers Technology for Automating Unstructured Clinical Data Extraction with Over 90% Accuracy BERKELEY HEIGHTS, N.J., April 29, 2025 /PRNewswire/ --...
NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform
FORT MYERS, Fla. and FREMONT, Calif., April 29, 2025 /PRNewswire/ -- NeoGenomics, Inc. (Nasdaq:NEO), a leading provider of oncology diagnostic...
Lirum Therapeutics’ LX-101 New Positive Data Selected for Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting
New York, NY, April 29, 2025 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on...
Combined General Meeting of May 21, 2025 – Availability of preparatory documents
Press Release Paris – April 29, 2025 – EUROAPI’s shareholders are invited to attend the Combined General Meeting to be...
Invitation to the presentation of ALK’s first quarter 2025 results on Tuesday, 6 May 2025
ALK (ALKB.DC / OMX: ALK B) will publish its results for the first quarter of 2025 in the morning on...
Invitation to the presentation of ALK’s first quarter 2025 results on Tuesday, 6 May 2025
ALK (ALKB.DC / OMX: ALK B) will publish its results for the first quarter of 2025 in the morning on...
AscellaHealth Honored as Silver Stevie® Award Winner in 2025 American Business Awards®
Stevie winners will be celebrated during gala event on June 10 in New York BERWYN, Pa., April 29, 2025 (GLOBE...
AscellaHealth Honored as Silver Stevie® Award Winner in 2025 American Business Awards®
Stevie winners will be celebrated during gala event on June 10 in New York BERWYN, Pa., April 29, 2025 (GLOBE...
Affimed Shows Higher Exposure of AFM24 is Associated with Significantly Higher Response Rates and Progression-Free Survival in Refractory NSCLC Patients at AACR Annual Meeting
An exposure-outcome analysis in 72 patients with refractory non-small cell lung cancer (NSCLC) who received AFM24 at 480 mg weekly...
Affimed Shows Higher Exposure of AFM24 is Associated with Significantly Higher Response Rates and Progression-Free Survival in Refractory NSCLC Patients at AACR Annual Meeting
An exposure-outcome analysis in 72 patients with refractory non-small cell lung cancer (NSCLC) who received AFM24 at 480 mg weekly...
Kriya Announces Thirteen Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2025
– Kriya’s platform includes fully integrated best-in-class manufacturing and research capabilities to support parallel advancement of a broad pipeline of...
Kriya Announces Thirteen Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2025
– Kriya’s platform includes fully integrated best-in-class manufacturing and research capabilities to support parallel advancement of a broad pipeline of...
Rakovina Therapeutics Showcases Preclinical Results of Novel AI-Discovered Cancer Therapies at AACR 2025
Data highlights novel PARP1 and ATR inhibitors with progress toward next-generation therapies for hard-to-treat malignanciesVANCOUVER, British Columbia, April 29, 2025...
Rakovina Therapeutics Showcases Preclinical Results of Novel AI-Discovered Cancer Therapies at AACR 2025
Data highlights novel PARP1 and ATR inhibitors with progress toward next-generation therapies for hard-to-treat malignanciesVANCOUVER, British Columbia, April 29, 2025...
Fate Therapeutics Announces Five Presentations on Off-the-Shelf CAR T-cell Product Platform at ASGCT Annual Meeting
Updated clinical and preclinical data showcase iPSC-derived off-the-shelf CAR T-cell therapy products for conditioning chemotherapy-free treatment across autoimmune and cancer...
Fate Therapeutics Announces Five Presentations on Off-the-Shelf CAR T-cell Product Platform at ASGCT Annual Meeting
Updated clinical and preclinical data showcase iPSC-derived off-the-shelf CAR T-cell therapy products for conditioning chemotherapy-free treatment across autoimmune and cancer...
Tonix Pharmaceuticals Presented Preclinical Data on Gastric Cancer Models at the American Association for Cancer Research (AACR) 2025 Annual Meeting
Combination treatment of TFF2 with anti-PD1 antibody was associated with the activation of cancer-killing CD8+ T Cells and limiting immune...
Tonix Pharmaceuticals Presented Preclinical Data on Gastric Cancer Models at the American Association for Cancer Research (AACR) 2025 Annual Meeting
Combination treatment of TFF2 with anti-PD1 antibody was associated with the activation of cancer-killing CD8+ T Cells and limiting immune...